• Return to Headlines

Shares of Illumina Inc Rank the Highest in Terms of EV/EBITDA Ratio in the Life Sciences Tools & Services Industry (ILMN, NEO, AMRI, TECH, BIO)

By Nick Russo

Below are the three companies in the Life Sciences Tools & Services industry with the highest enterprise value to EBITDA (EV/EBITDA) ratios. EV/EBITDA is an important metric used in valuing comparable companies. It is capital structure neutral and generally the lower the ratio, the more undervalued the company is believed to be.

Illumina Inc ranks highest with a an EV/EBITDA ratio of 41.45. Neogenomics Inc is next with a an EV/EBITDA ratio of 37.34. Albany Molecular ranks third highest with a an EV/EBITDA ratio of 31.80.

Bio-Techne Corp follows with a an EV/EBITDA ratio of 29.12, and Bio-Rad Labs-A rounds out the top five with a an EV/EBITDA ratio of 28.97.

SmarTrend recommended that subscribers consider buying shares of Bio-Rad Labs-A on April 17th, 2018 as our technology indicated a new Uptrend was in progress when shares hit $262.43. Since that recommendation, shares of Bio-Rad Labs-A have risen 11.2%. We continue to monitor Bio-Rad Labs-A for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest ev/ebitda ratio illumina inc neogenomics inc :amri albany molecular bio-techne corp bio-rad labs-a

Ticker(s): ILMN NEO TECH BIO